It’s not. Of course.
It may be the first triple immunotherapy (3 checkpoint inhibitors), given in a neo-adjuvant setting, in glioblastoma.
Still cool, less catchy
(Or maybe I don’t understand “world-first” ?)
> It is the first documented use of neoadjuvant triple immunotherapy in glioblastoma
If the headline read "world's first" then it would imply what you understood
It’s not. Of course.
It may be the first triple immunotherapy (3 checkpoint inhibitors), given in a neo-adjuvant setting, in glioblastoma.
Still cool, less catchy
(Or maybe I don’t understand “world-first” ?)